Brief: Yidu Tech Inc Says Diabetes Digital Therapeutics Product Based On Diabetes Digital Therapeutics Approved By U.S. FDA
26/06/2023 05:09
June 26 (Reuters) - Yidu Tech Inc 2158.HK :
* YIDU TECH INC - DIABETES DIGITAL THERAPEUTICS PRODUCT
BASED ON
DIABETES DIGITAL THERAPEUTICS APPROVED BY U.S. FOOD AND DRUG
ADMINISTRATION
* YIDU TECH - DIABETES DIGITAL THERAPEUTICS PRODUCT FOR
CHINA
DEVELOPED BY CO HAS BEEN APPROVED BY HAINAN MEDICAL PRODUCTS
ADMINISTRATION OF CHINA
* YIDU TECH - DIABETES DIGITAL THERAPEUTICS PRODUCT FOR
CHINA
RECEIVED MEDICAL DEVICE REGISTRATION CERTIFICATE OF PEOPLE'S
REPUBLIC OF CHINA
Further company coverage: 2158.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Yidu Tech
See all newsBrief: Yidu Tech Says Cloud Affiliate Wins Bid For Construction Project At Xiangya Hospital
Brief: Yidu Tech Enters MoU For Proposed Acquisition Of Co Engaged In Online Doctors’ Platform
Brief: Yidu Tech Says Cloud Wins Chongqing Fuling Hospital Data Center Project
Brief: Yidu Tech Says Affiliate Wins Smart Clinical Upgrade Project Worth RMB9.08 MLN
Brief: Yidu Tech's Unit Wins Singapore Health Services Dr Buddy Project Worth S$2.3 Mln